Navigation Links
Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results
Date:11/7/2007

nd positioning pixantrone for its phase III EXTEND data release by mid-2008 provides CTI with multiple shots at moving closer to our goal of breaking even," said James A. Bianco, M.D., President and CEO of CTI. "We expect exciting new randomized clinical trial data on ZEVALIN to be reported on first-line therapy in follicular NHL at upcoming clinical meetings providing the possibility of expanding its label in 2008 -- potentially making 2008 a pivotal year for CTI and its shareholders."

CTI has entered into an agreement to acquire ZEVALIN from Biogen Idec, Inc. Completion of that acquisition is subject to certain closing conditions, including obtaining third party consents. CTI expects to complete the acquisition in the fourth quarter of 2007, at which time CTI will acquire the rights to develop, market and sell ZEVALIN in the United States.

As a result of the acquisition of Systems Medicine, Inc. (SM) during the quarter, the net loss attributable to common shareholders for the quarter and the nine months ended September 30, 2007 included a non-cash acquired in-process research and development charge of $21.3 million allocated to the purchase of SM. Excluding this in-process research and development charge, operating expenses increased modestly primarily as a result of manufacturing activity in preparation for submission of a marketing application for XYOTAX(TM) (paclitaxel poliglumex, CT-2103) in Europe as well as costs related to initiating the phase III clinical trials, PGT307 and PIX303, for XYOTAX and pixantrone (BBR 2778), respectively. Including this charge, the total net loss attributable to common shareholders for the quarter totaled $52.6 million ($1.09 per share) compared to $27.8 million ($1.00 per share) for the same period in 2006. For the nine months ended September 30, 2007, CTI posted a net loss attributable to common shareholders of $109.2 million ($2.55 per share) compared to $100.2 million ($3.93 per share) for the same period in 2006
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
2. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
3. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
4. Cell Therapeutics, Inc. (CTI) CIBC and Rodman & Renshaw Healthcare Conference Presentations to be Webcast
5. Cell Therapeutics, Inc. (CTI) to Report Third Quarter Financial Results on November 8
6. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
7. Haemacure Reports Third Quarter 2007 Results
8. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
9. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
10. MDS Reports Third Quarter 2007 Results
11. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... Center, FL (PRWEB) May 25, 2013 Absolute ... one of many of the NALA’s businesses throughout the country ... Amshel chose to participate in the nationwide event as he ... a Lieutenant Colonel in the Army. He said, “I wanted ... the community I serve, but I live here too.” , ...
(Date:5/25/2013)... 2013 The latest report from ... bowel syndrome (IBS) to bloating, constipation, diarrhea and ... long-lasting, embarrassing, frustrating and difficult health issues to ... health have provided a cure for these ... contributing to digestive health issues, a healthy diet ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 According ... Emergency Management Market, 2013–2018", published by MarketsandMarkets is ... a CARC of 5.54% which analyzes and studies ... North America, Europe, Asia, and Rest of the ... Market Data Tables , 87 Figures ...
(Date:5/25/2013)... 25, 2013 According to world-renowned scholars, ... and powerful women that ever lived. Cleopatra’s legendary beauty ... of the most powerful men in her time. Cleopatra ... to keep her skin glowing and fresh, from her ... wax, maringa oil and cyprus grass. , Cleopatra was ...
(Date:5/25/2013)... CA (PRWEB) May 25, 2013 IBISWorld estimates ... grow at an average annual rate of 28.7% to $1.0 ... 17.9% in 2013. From 2002 and 2008, no new cell ... Culbert, causing relatively modest growth during that period. In the ... approved six new products. This factor contributed to the industry's ...
Breaking Medicine News(10 mins):Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 2Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 3Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 4Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 3
... both lauds and supports the Institute of Medicine,s ... Education, and Practice . The recommendations will ... judgment and preserving public trust in medicine. ... of Physicians Foundation and the European Federation of ...
... team has made the world-first discovery a ,pied piper, ... molecules into the nucleus of the cell, and could ... cancers as well as leukemia. , Uncovered by two ... Research (WAIMR) led by Associate Professor Evan Ingley and ...
... April 28 Gene Network Sciences, Inc. today announced ... Wyeth Research & Development and a leader in pharmaceutical ... as President of Wyeth Research & Development in 2008, ... had joined Wyeth in November 2000 and has been ...
... BANNOCKBURN, Ill., April 28 Healthy Life Laboratories has announced ... use by diabetes patients and healthcare professionals - the ... of its kind for use on iPhone and ... better understand the relationship between blood glucose and hemoglobin A1c.Maintaining ...
... Combat Spread of VirusesLAS VEGAS, April 28 Skinvisible, ... company of patented skincare and medical dermatology products, has ... in killing the H1N1 swine flu virus found in ... studies with Skinvisible,s Hand Sanitizer Lotion; DermSafe. ...
... Institute of Allergy and Infectious Diseases (NIAID), part ... China,s Henan Provincial Bureau of Health will meet ... an implementation arrangement intended to foster research on ... multidrug-resistant tuberculosis (MDR TB). The Henan Provincial Bureau ...
Cached Medicine News:Health News:Statement by Christine K. Cassel, MD, President and CEO of the ABIM Foundation on the Institute of Medicine Report: Conflict of Interest in Medical Research, Education, and Practice 2Health News:WA discovery a key to blood cell development 2Health News:Gene Network Sciences Names Former Wyeth President of R&D Robert Ruffolo to SAB 2Health News:Gene Network Sciences Names Former Wyeth President of R&D Robert Ruffolo to SAB 3Health News:Healthy Life Laboratories Announces Hemoglobin A1c iPhone Application 2Health News:Skinvisible's DermSafe(R) Hand Sanitizer Kills Swine Flu Virus 2Health News:Skinvisible's DermSafe(R) Hand Sanitizer Kills Swine Flu Virus 3Health News:NIAID and Chinese officials sign agreement to foster TB research in China's Henan province 2
(Date:5/23/2013)... -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced ... Chief Executive Officer of Neurocrine Biosciences, will be presenting at ... Conference in Boston.   The live presentation takes ... / 8:20 a.m. Pacific Time.  The presentation will be webcast ... http://www.neurocrine.com . If you are unable to ...
(Date:5/23/2013)... , May 23, 2013  MGC Diagnostics Corporation ... global medical technology company, today scheduled a conference call ... of fiscal year 2013, ended April 30, 2013. The ... May 30, 2013. The Company will report financial results ... the markets close on Thursday, May 30, 2013. ...
(Date:5/23/2013)... SAN DIEGO , May 23, 2013 /PRNewswire/ ... the prostate cancer treatment continuum was highlighted prominently ... the American Urological Association (AUA), in San Diego.  ... invasive high intensity focused ultrasound (HIFU) technology, the ... localize disease, and for urologists to consider minimally ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6
... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
Inquire...
... autoimmune testing feature single-well ANA screen and ... reflex tests including dsDNA, and 6 individual ... (La), Scl-70 and Jo-1. In addition, our ... of products for Cardiolipins (IgA, IgG, IgM), ...
... for autoimmune testing feature single-well ANA screen ... specific reflex tests including dsDNA, and 6 ... SS-B (La), Scl-70 and Jo-1. In addition, ... line of products for Cardiolipins (IgA, IgG, ...
Medicine Products: